ArticleEuropean radiology experimental2026
Noncontrast CT-based habitat analysis for differentiating hemorrhagic transformation from contrast extravasation after endovascular therapy of acute ischemic stroke.
Article in European radiology experimental, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesHemorrhagic transformation (HT) is a serious and common complication after endovascular therapy (EVT) in patients with acute ischemic stroke (AIS). This study aimed to evaluate the diagnostic value of habitat analysis in differentiating HT from contrast extravasation (CEx) within hyperdense areas (HDAs) after EVT, and to assess whether the preoperative imaging features provide additional diagnostic value. MATERIALS AND
methodsThis retrospective study included 187 AIS patients with HDAs. A stratified three-fold cross-validation was used to split the dataset into training and validation cohorts, and preoperative hyperdense artery sign (HAS) status and clinical characteristics were collected. Habitat analysis was performed using the k-means clustering algorithm applied to postoperative noncontrast CT. The radiomics model, habitat model, and corresponding combined models integrating HAS and clinical characteristics were developed. Diagnostic performance was evaluated by the area under the receiver operating characteristic curve (AUC).
resultsThe optimal k-value was determined to be 5. In differentiating HT from CEx of HDA, the habitat model achieved the highest AUC values of 0.89 and 0.82 in the training and validation cohorts, respectively. Habitat analysis showed improved diagnostic performance compared with the radiomics analysis (AUCs were 0.81 and 0.75 in the training and validation cohorts). The combined model integrating preoperative imaging features, clinical characteristics, and habitat features did not improve performance.
conclusionHabitat analysis outperformed radiomics analysis in differentiating HT from CEx of HDAs after EVT on NCCT. Five‑cluster habitat analysis revealed intralesional heterogeneity within HDAs in AIS patients, supporting its potential as a novel tool for clinical decision‑making. KEY POINTS: Question Differentiation of HT from CEx in post-EVT HDA on non-contrast CT remains a clinical challenge in AIS. Findings Habitat model achieved AUCs up to 0.89 in the training cohort and 0.82 in the validation cohort, outperforming radiomics analysis for differentiating post-EVT HDA and revealed HDA heterogeneity. Relevance Statement Habitat analysis revealed intralesional heterogeneity in the HDA and outperformed radiomics analysis in differential diagnosis on noncontrast CT, which is widely available in most stroke centers. Our findings suggest its potential as a novel clinical decision-making tool.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.